A. V. Akkooi

ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee

B. Schilling, S. Puig, V. Sondak, 2020 .

LBA39 Personalized combination of neoadjuvant domatinostat, nivolumab (NIVO) and ipilimumab (IPI) in stage IIIB-D melanoma patients (pts) stratified according to the interferon-gamma signature (IFN-γ sign): The DONIMI study

R. Scolyer, S. Cornelissen, G. Long, 2021, Annals of Oncology.

ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee

B. Schilling, S. Puig, V. Sondak, 2020 .

ESMO consensus conference recommendations on the management of metastatic melanoma: the ESMO Guidelines Committee.

B. Schilling, S. Puig, V. Sondak, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Sentinel node biopsy in melanoma: Current controversies addressed.

M.F. Madu, M.W.J.M. Wouters, A.C.J. van Akkooi, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

3-year relapse-free survival (RFS), overall survival (OS) and long-term toxicity of (neo)adjuvant ipilimumab (IPI) + nivolumab (NIVO) in macroscopic stage III melanoma (OpACIN trial)

T. Schumacher, K. Sikorska, C. Blank, 2019, Annals of Oncology.

18-months relapse-free survival (RFS) and biomarker analyses of OpACIN-neo: A study to identify the optimal dosing schedule of neoadjuvant (neoadj) ipilimumab (IPI) + nivolumab (NIVO) in stage III melanoma

K. Shannon, A. Broeks, R. Scolyer, 2019, Annals of Oncology.

Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma

J. Taube, M. Ross, J. Wargo, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Recent developments in lymph node surgery for melanoma

A. V. van Akkooi, A. Hayes, A. V. Akkooi, 2019, The British journal of dermatology.